Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

9728 reported adverse events

Drugs of this class: AGALSIDASE BETA PEGUNIGALSIDASE ALFA

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] class:

# Side effect Count
0 PYREXIA 543
1 PAIN 540
2 MALAISE 504
3 NAUSEA 501
4 CHILLS 494
5 FATIGUE 468
6 DYSPNOEA 437
7 VOMITING 394
8 HEADACHE 390
9 WEIGHT DECREASED 356
See all common reactions for Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLOBOTRIAOSYLCERAMIDE INCREASED 103 0.9810
1 GLOBOTRIAOSYLSPHINGOSINE INCREASED 189 0.9643
2 FABRY'S DISEASE 23 0.6571
3 ANGIOKERATOMA 31 0.3647
4 ANTIBODY TEST 19 0.2603
5 NEUTRALISING ANTIBODIES POSITIVE 66 0.1583
6 DRUG SPECIFIC ANTIBODY ABSENT 18 0.0882
7 ANTIBODY TEST NEGATIVE 17 0.0863
8 DRUG SPECIFIC ANTIBODY PRESENT 220 0.0338
9 RENAL TRANSPLANT 87 0.0241
See all enriched reactions for Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]